Use of Medications With Somnolence Adverse Effects and Somnolence Symptoms Among Older Adults in the U.S.

ObjectivesNearly half of older adults experience somnolence, but the link between medications with somnolence as an adverse effect and somnolence is unclear. This study investigated the association between polypharmacy and somnolence symptoms (excessive sleepiness or long sleep duration).MethodsData from the National Social Life, Health, and Aging Project (NSHAP) 2010-2011 was used to examine the concurrent use of medications with potential somnolence as an adverse effect and the prevalence of somnolence symptoms.ResultsAmong the 2638 older adults (mean, 71 years), 49.0% used medications with potential somnolence adverse effects. The adjusted prevalence of somnolence symptoms was significantly higher among those using three or more medications (58%) than those not using such medications (31.2%) (difference, 20.4%; 95% CI 12.5, 28.4).DiscussionIn this cross-sectional study, medications with somnolence as a potential adverse effect were commonly used, and the findings suggest a link between polypharmacy and the increased risk of somnolence symptoms.

Authors

Institutions

Publication Details

Journal
Journal of Aging and Health
Published
2024-11-26
DOI
https://doi.org/10.1177/08982643241298734
Primary Topic
Sleep and related disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of Medications With Somnolence Adverse Effects and Somnolence Symptoms Among Older Adults in the U.S.

Jocelyn Wilder, Dima M. Qato, Diane S. Lauderdale
6 links
Journal of Aging and Health
Sleep and related disorders
article

Use of Medications With Somnolence Adverse Effects and Somnolence Symptoms Among Older Adults in the U.S.

Jocelyn Wilder, Dima M. Qato, Diane S. Lauderdale
article en

Abstract

ObjectivesNearly half of older adults experience somnolence, but the link between medications with somnolence as an adverse effect and somnolence is unclear. This study investigated the association between polypharmacy and somnolence symptoms (excessive sleepiness or long sleep duration).MethodsData from the National Social Life, Health, and Aging Project (NSHAP) 2010-2011 was used to examine the concurrent use of medications with potential somnolence as an adverse effect and the prevalence of somnolence symptoms.ResultsAmong the 2638 older adults (mean, 71 years), 49.0% used medications with potential somnolence adverse effects. The adjusted prevalence of somnolence symptoms was significantly higher among those using three or more medications (58%) than those not using such medications (31.2%) (difference, 20.4%; 95% CI 12.5, 28.4).DiscussionIn this cross-sectional study, medications with somnolence as a potential adverse effect were commonly used, and the findings suggest a link between polypharmacy and the increased risk of somnolence symptoms.

Journal of Aging and HealthVol. 37(10)
University of Southern California (US), Chicago Department of Public Health (US), California Southern University (US), University of Illinois Chicago (US), University of Chicago (US), National Opinion Research Center (US)
National Institute on Aging
Openalex Percentile: Top 74%
Sleep and related disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.